Bharat Immunological Biological Corporation Ltd vs Brawn Biotech Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: May 18, 2026

Key Highlights

The Latest Trading Price of Bharat Immunological & Biological Corporation Ltd is ₹ 17.47 as of 18 May 15:30 . The P/E Ratio of Bharat Immunological & Biological Corporation Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe P/E Ratio of Brawn Biotech Ltd changed from 0 on March 2021 to 0 on March 2025 . This represents a CAGR of 0.0% over 5 years The Market Cap of Bharat Immunological & Biological Corporation Ltd changed from ₹ 196.47 crore on March 2021 to ₹ 0 crore on March 2025 . This represents a CAGR of -100.00% over 5 yearsThe Market Cap of Brawn Biotech Ltd changed from ₹ 6.63 crore on March 2021 to ₹ 4.88 crore on March 2025 . This represents a CAGR of -5.95% over 5 years The revenue of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Brawn Biotech Ltd for the Dec '25 is ₹ 4.4 crore as compare to the Sep '25 revenue of ₹ 4.98 crore. This represent the decline of -11.65% The ebitda of Bharat Immunological & Biological Corporation Ltd for the Dec '25 is ₹ 0 crore as compare to the Sep '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Brawn Biotech Ltd for the Dec '25 is ₹ 0.08 crore as compare to the Sep '25 ebitda of ₹ 0.1 crore. This represent the decline of -20% The net profit of Bharat Immunological & Biological Corporation Ltd changed from ₹ 0 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of 0.0% The net profit of Brawn Biotech Ltd changed from ₹ -0.53 crore to ₹ 0.05 crore over 7 quarters. This represents a CAGR of NaN% The Dividend Payout of Bharat Immunological & Biological Corporation Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Brawn Biotech Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Bharat Immunological & Biological Corporation Ltd

The Bharat Immunologicals and Biologicals Corporation Limited (BIBCOL) is a Central Public Sector Unit, under the Department of Biotechnology, Ministry of Science and Technology.
BIBCOL was incorporated in 1989.
The Company is engaged in the manufacture of Oral Polio Vaccine (OPV) , Zinc Tablets and Diarehha management Kit and BIB Sweet Tablets. The company's manufacturing unit is located in Bulandshahr Dist., Uttar Pradesh.
BIBCL installed a plant of 100 mln units.
Commercial production of the OPV started from Jan'96. The company has received firm orders for supply of OPV from the Ministry of Health and Family Welfare, Government of India, for use in the national immunisation programme.

About Brawn Biotech Ltd

Brawn Biotech Limited was originally incorporated in the name of Brawn Pharmaceuticals Limited in November, 1985.
Thereafter, the name of the Company was changed from Brawn Pharmaceuticals Limited to Brawn Biotech Limited in November, 2010.
Brawn, with its inception barely 38 years back has today evolved into a fully integrated, healthcare group, marking its presence in India and across the globe. The Company possess product registration with major health and govt. institutions throughout India and worldwide.
Headed and represented by a team of skilled industry experts with impressive educational backgrounds and broad experience, the Company has spread its wings in expansion in the domestic as well as in the international markets beyond the existing horizon to stand among the leading Indian HealthCare products distribution Companies.

FAQs for the comparison of Bharat Immunological & Biological Corporation Ltd and Brawn Biotech Ltd

Which company has a larger market capitalization, Bharat Immunological & Biological Corporation Ltd or Brawn Biotech Ltd?

Market cap of Bharat Immunological & Biological Corporation Ltd is 75 Cr while Market cap of Brawn Biotech Ltd is 5 Cr

What are the key factors driving the stock performance of Bharat Immunological & Biological Corporation Ltd and Brawn Biotech Ltd?

The stock performance of Bharat Immunological & Biological Corporation Ltd and Brawn Biotech Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Bharat Immunological & Biological Corporation Ltd and Brawn Biotech Ltd?

As of May 18, 2026, the Bharat Immunological & Biological Corporation Ltd stock price is INR ₹17.47. On the other hand, Brawn Biotech Ltd stock price is INR ₹19.0.

How do dividend payouts of Bharat Immunological & Biological Corporation Ltd and Brawn Biotech Ltd compare?

To compare the dividend payouts of Bharat Immunological & Biological Corporation Ltd and Brawn Biotech Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.